Decitabine activates type I interferon signaling to inhibit p53-deficient myeloid malignant cells

Published: 28 May 2021| Version 1 | DOI: 10.17632/4kwg2ydz2g.1
Contributors:
Jiale Wu, Yuntong Li, Jiaqi Wu, Huaxin Song, Yigang Tang, Ni Yan, Lili Wu, Sujiang Zhang, ChunKang Chang, Min Lu

Description

Raw data of manuscript entitled "Decitabine activates type I interferon signaling to inhibit p53-deficient myeloid malignant cells"

Files

Steps to reproduce

See accompanied publication

Institutions

Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai Institute of Hematology

Categories

Cancer, Acute Myelogenous Leukemia, Protein P53

Licence